bioRxivNeurosciencePreprint
Identifying Novel Candidates for Re-Purposing as Potential Therapeutic Agents for Alzheimer’s disease
Clive G. BallardiD, Byron CreeseiD, Ariana P. GattiD, Patrick DohertyiD, Paul T. FrancisiD, D Whitfield, Anne CorbettiD, J Corcoran, Diane P. HangeriD, Sandrine ThuretiD, Richard KillickiD, Gareth Haydn WilliamsiD
Abstract
The current paper describes the identification of novel candidate compounds for repositioning as treatments for Alzheimers disease (AD) from the CMAP library. Candidate compounds were identified based on inverse correlation with transcriptome signatures developed from meta-analyses of Alzheimer RNA expression studies using the SPIED platform. The 78 compounds with a significant inverse correlation were taken forward into an in vitro programme using 6 well validated screening assays relevant to potential treatment targets in AD. Nineteen pf the compounds were hits in at least 2 of these assays. A description of each of these compounds is presented.
- organism: human
- assay: bulk RNA-seq
- research focus: drug response / drug discovery
- approach: statistical model
- Citations
- 7
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Artificial intelligence based computational framework for drug-target prioritization and inference of novel repositionable drugs for Alzheimer's disease
Shingo Tsuji, Takeshi Hase, … Hiroshi Tanaka·Alzheimer s Research & TherapyPeer-reviewed·May 3, 2021
- Machine Learning Identifies Novel Candidates for DrugRepurposing in Alzheimer's Disease
Steve Rodriguez, Clemens B. Hug, … Artem Sokolov·Nature CommunicationsPeer-reviewed·Feb 15, 2021
- Network pharmacology-based discovery and experimental validation of novel drug repurposing candidates in Alzheimer's Disease
Attila Jones, Tina Loeffler, … Madhav Thambisetty·bioRxiv·Mar 9, 2026
- Fluphenazine, an antipsychotic compound, ameliorates Alzheimer's disease by clearing amyloid beta accumulation in C. elegans
Mayur Nimbadas Devare, Victoria Le, … Matt R. Kaeberlein·GeroSciencePeer-reviewed·Sep 9, 2025
- DReAmocracy: A Method to Capitalize on Prior Drug Discovery Efforts to Highlight Candidate Drugs for Repurposing
Kyriaki Savva, Margarita Zachariou, … George M. Spyrou·International Journal of Molecular SciencesPeer-reviewed·May 13, 2024
- AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discovery
Frances Potjewyd, Joel K. Annor‐Gyamfi, … Alison Donnelly Axtman·Alzheimer s & Dementia Translational Research & Clinical InterventionsPeer-reviewed·Jan 1, 2022